腹水貯留の英語

同種由来のＡＭＦ（自己分泌運動性因子）類の投与が、癌の増殖抑制、腹水貯留の抑制、癌転移の抑制等に有用であることを見出した。例文帳に追加

An administration of a homologously derived AMF (autocrine motility factor) is found to be useful for suppressing cancer growth, ascites accumulation, cancer transition and the like. - 特許庁

細菌感染によって惹起される炎症症状、特に炎症部位への胸水や腹水等の体液貯留や血中の好中球増多等の症状を軽減する作用を有する炎症に伴う症状の軽減剤を提供することを課題とする。例文帳に追加

To provide a mitigating agent for symptoms caused by inflammation, having effect for inflammatory symptoms caused by bacterial infection, especially for the symptoms of fluid retention such as retention of pleural fluid or abdominal dropsy in inflammatory region and neutrophilic leukocytosis in blood. - 特許庁

従って、癌、特に固形癌、血管腫などの腫瘍の増殖抑制に、慢性関節リューマチ、乾癬、強皮症、癌性腹水・胸水貯留などの疾病の予防・治療に、また、糖尿病性網膜症等の網膜疾患や血管新生緑内障などの眼疾患の予防・治療に有用である。例文帳に追加

Accordingly, the agent is useful for the suppression of the proliferation of cancer, especially tumors such as solid cancer and vascular neoplasm, the prevention/treatment of diseases such as chronic rheumatoid arthritis, psoriasis, scleroderma, and cancerous ascites/accumulation of pleural effusion, and the prevention/treatment of retinal diseases such as diabetic retinopathy and ophthalmic diseases such as neovascular glaucoma. - 特許庁

ヒト型ラクトフェリンを有効成分とする組成物を経口的あるいは非経口的に摂取あるいは投与することにより、細菌感染によって惹起される炎症症状、特に炎症部位への胸水や腹水等の体液貯留や血中の好中球増多等の症状を効果的に軽減することが可能となる。例文帳に追加

This agent is obtained by including human lactoferrin as the active ingredient and can effectively mitigate inflammatory symptoms caused by bacterial infection, especially the symptoms of fluid retention such as retention of pleural fluid or abdominal dropsy in inflammatory region and neutrophilic leukocytosis in blood by being orally or parenterally taken or administered. - 特許庁

ヒトまたは動物の血管新生誘導能が低い細胞に血管新生因子の遺伝子を導入し、血管新生因子を高発現する細胞を選択することにより、血行性転移、リンパ行性転移、播種、癌性腹水または胸水貯留、癌性悪液質およびそれらに基づく宿主の生命期間の短縮を獲得した細胞を製造する。例文帳に追加

The cell which has obtained hematogenous metastasis, lymphogenous metastasis, dissemination, cancerous ascites or pleuritis, cancerous cachexia and a shortened host life time caused thereby is produced by introducing a gene of a neovascular factor into a human or animal cell having low neovascular induction potency and selecting a cell highly expressing the neovascular factor. - 特許庁